Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

307

HTML

2314

Figures (1-2)

130

Tables (1-4)

153

Sum=2904

Oct 15, 2001 (publication date) through Jul 20, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Oct 15, 2001; 7(5): 702-705
Published online Oct 15, 2001. doi: 10.3748/wjg.v7.i5.702

Table 3 The effect of As₂O₃ and/or PDD on HepA implanted tumor in mice (n = 10)

^aP ＜ 0.01, F = 54.05, vs As₂O₃ or PDD alone.

Citation: Wang W, Qin SK, Chen BA, Chen HY. Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma. World J Gastroenterol 2001; 7(5): 702-705
URL: https://www.wjgnet.com/1007-9327/full/v7/i5/702.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i5.702